Echinacea angustifolia
Natural health product licensed in Canada
- Licence holder
- Orbus Pharma Inc.
- NPN or DIN-HM
- 80000010
- Status
- Active licence
- Licence date
- 28 May 2004
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- (M) non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Lécithine, Dioxyde de titane, Glycérine, Gélatine, Huile de fève de soja, Acid Fuchsin D, Dioxyde de silicium, Eau purifiée, Bleu brillant, sel de sodium FCF
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Chacun | 1 Tous les jours |
Uses authorised in Canada
Traditionally used to fight off colds, flus and infections. Acts as supportive therapy in the treatment of colds, flus, upper respiratory infections and urinary infections. Traditionally used for the relief of sore throat due to colds.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Not recommended during pregnancy and lactation. Not recommended to people with known allergies to other members of the Asteraceae family such as ragweed. Not recommended if you suffer from or are treated for autoimmune disorders.
Source
Official Health Canada record, licence 80000010
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.